Active Ingredient: ERAVACYCLINE DIHYDROCHLORIDE
Proprietary Name: XERAVA
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 50MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211109
Product Number: 001
Approval Date: Aug 27, 2018
Applicant Holder Full Name: TETRAPHASE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
